Mycoplasma Plate Antigens Market Size to Hit USD 880 Million by 2032, Detailed Forecast Report
Mycoplasma Plate Antigens Market Overview:
The global mycoplasma plate antigens market was valued at US$ 465 Million in 2021, and is projected to reflect a y-o-y growth rate of 6.5% in 2022 to reach US$ 495.35 Million in 2022. The market is expected to exhibit a CAGR of nearly 6%from 2022-2032, reaching US$ 880 Million by the end of the said forecast period.
Mycoplasma plate antigens are used to detect antibodies against the etiologic agent of mycoplasma strains that cause chronic respiratory disease in chickens and infectious sinusitis in turkeys. Nasal discharge, coughing, airsacculitis, and respiratory rales are some of the most common symptoms of the disease.
Early detection of these diseases using commercially available mycoplasma plate antigens, kits, and reagents can help to avoid other negative consequences such as reduced feed conversion and egg production. As a result, it can help to mitigate the severe economic losses suffered by broiler and turkey production companies. The development of safe and effective vaccines directed against mycoplasma antigens is the best solution for controlling this disease.
Get a Sample PDF Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-10033
Key Segments Covered in the Mycoplasma Plate Antigens Market Report
- Plate Agglutination Mycoplasma Plater Antigen Test Products
- Mycoplasma Plate Antigens
- Mycoplasma Plate Antigens- Control Serum
- Plate Antigens-Negative Control Serum
- Confirmatory Mycoplasma Plate Antigens Testing Reagents
- Mycoplasma Whole Organism
- Mycoplasma Antiserum
- Negative Serum
- Mycoplasma Plate Antigens for Drug Development
- Mycoplasma Plate Antigens for Infection Medicine
- Mycoplasma Plate Antigens for Veterinary Research
- Mycoplasma Plate Antigens for Other Applications
End User Type:
- Mycoplasma Plate Antigens for Veterinary Hospitals
- Mycoplasma Plate Antigens for Poultry Veterinary Clinics
- Mycoplasma Plate Antigens for Academic and Research Institutes
- Mycoplasma Plate Antigens for Pharma and Biotech Companies
- North America
- Latin America
- Western Europe
- Eastern Europe
- Middle East & Africa
Ask to Analyst: https://www.futuremarketinsights.com/ask-question/rep-gb-10033
Key Market Players:
Some of the key players present in global mycoplasma plate antigens market include –
- Charles River
- Prospec-Tany Technogene Lt
- Abnova Corporation
- Qiagen N.V
- MyBiosource, Inc.
Which are Some Prominent Drivers Spearheading Mycoplasma plate antigens Market Growth?
Mycoplasma infection can occur in humans and other animals, usually as a result of close contact with infected poultry. In humans, these infections are associated with mild respiratory disease and can cause mild to severe illness. As a result, diagnosing mycoplasma plate antigens has become a common practice.
Many biochemical and physiological properties of some reagents and chemicals are usually insufficient for strain identification and classification based on the order mycoplasmatales. As a result, the serological properties of mycoplasma plate antigens are widely used for such purposes.
In comparison to other available reagents, these mycoplasma plate antigens provide more accurate quantification of antibodies against mycoplasma. These serological reactions are successfully used to identify antibodies against mycoplasma; however, research is still being conducted to determine the various cell components responsible for these reactions.
Buy this Report Now: https://www.futuremarketinsights.com/checkout/10033
How is North America Contributing to the Growth of the Mycoplasma plate antigens Market?
Geographically, the global Mycoplasma Plate Antigens market is divided into the following key regions: North America, Latin America, Europe, South Asia, East Asia, Oceania, and the Middle East and Africa. In the forecasted period, North America is expected to account for one of the largest shares of the global mycoplasma plate antigens market. Increased drug development, infection medicine, veterinary research, and other cell-based studies are among the drivers for the region of North America.
Why is Asia-Pacific Emerging as an Opportunistic Mycoplasma plate antigens Market?
China and India are expected to grow at a steady rate in the Asian mycoplasma plate antigens market over the forecast period. Factors such as a significant increase in import reforms for medical and life science products, as well as the presence of local manufacturers with R&D facilities in the region, are expected to drive the growth of the Mycoplasma Plate Antigens market in the region. Among other countries in the region, Japan, which has established R&D in medical devices as well as developed healthcare infrastructure, will contribute to the country’s market growth for mycoplasma plate antigens.
Explore Top Reports from Healthcare Market:
Blood Collection Devices Market Insights : The global Blood Collection Devices Market is poised to expand at a CAGR of 6.3% to cross a valuation of US$ 11 Bn by 2032, up from US$ 6 Bn in 2021.
Radial Compression Devices Market Forecast : The global Radial Compression Devices Market value at US$ 232.5 Mn in 2022 and is expected to reach US$ 504.0 Mn by 2031, finds Future Market Insights (FMI) in a recent market survey.
Bioabsorbable Stents Market Research : The global bioabsorbable stents market is expected to display a CAGR of 5.95% during the forecast period.
Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.
Future Market Insights,
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
For Sales Enquiries: email@example.com
LinkedIn| Twitter| Blogs